Trials / Completed
CompletedNCT00151749
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 260 (planned)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to see how safe and effective and tolerable the use of WelChol® is for type 2 diabetes when added to insulin alone or in combination with other anti-diabetic drugs
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colesevelam hydrochloride |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-09
- Last updated
- 2012-01-18
Locations
47 sites across 3 countries: United States, Mexico, Peru
Source: ClinicalTrials.gov record NCT00151749. Inclusion in this directory is not an endorsement.